Page last updated: 2024-08-18

cdaa and gw9662

cdaa has been researched along with gw9662 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hu, P; Peng, M; Ren, H; Sun, Z; Xiang, H; Xiao, J; Xu, J1

Other Studies

1 other study(ies) available for cdaa and gw9662

ArticleYear
GW9662 ameliorates nonalcoholic steatohepatitis by inhibiting the PPARĪ³/CD36 pathway and altering the gut microbiota.
    European journal of pharmacology, 2023, Dec-05, Volume: 960

    Topics: Animals; Diet, High-Fat; Gastrointestinal Microbiome; Liver; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; PPAR gamma; RNA, Ribosomal, 16S

2023